From reducing administrative workload to navigating ‘alien intelligence,’ this month’s column takes a practical look at ...
Cassava Sciences (SAVA) said it will change its name to Filana Therapeutics, reflecting its focus on developing drugs that target the filamin A protein to treat central nervous system disorders. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results